Stacy Fisher+FollowGame-Changing HIV Jab, But Who Gets It?The FDA just approved a twice-a-year HIV prevention shot that could nearly wipe out new infections—seriously, it’s that effective. But here’s the kicker: the price tag is wild ($28k+ a year in the US!) and global aid cuts mean millions who need it most might never see it. Experts say it could be made for $25, but big pharma’s holding the keys. Feels like a life-saving breakthrough stuck behind a paywall, right? #HIVPrevention #HealthEquity #BigPharma #Health #BodyHealth1610Share
Allison Bauer+FollowCould This $25 Shot End HIV?A new HIV-prevention shot, lenacapavir, is about to hit the US, and get this: researchers say it could be made for just $25 a year! But the pharma giant behind it might charge up to $25,000 instead. Activists and experts are calling out the huge markup, saying affordable access could actually end the HIV pandemic. Imagine if a life-saving drug was finally cheap enough for everyone who needs it. Will Gilead step up or stick to sky-high prices? #HIVPrevention #HealthNews #BigPharma #Health #BodyHealth8639Share
Michelle Chen+FollowWhy Custom Meds Are a Game ChangerEver wonder why some people need meds made just for them? Harvard Health says compounded medications are a lifesaver when off-the-shelf drugs don’t cut it—think allergies, weird dosages, or even just making medicine taste better for kids. Meanwhile, big pharma’s spending millions to keep their grip on the market and even suing compounding pharmacies. Kinda wild how much goes on behind the scenes just to get the right meds! #Healthcare #Pharmacy #BigPharma #CompoundedMeds #PatientCare #Health112Share
